Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Colin John Meyer currently holds 81,633 shares of REATA PHARMACEUTICALS INC (RETA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Colin John Meyer has been a net seller of RETA stock. They have purchased $223.8K and sold $26.4M worth of shares.
Colin John Meyer's most recent insider trade was on Sep 26, 2023, when they sold 81,633 shares at $0.00 per share.
Colin John Meyer serves as Executive at REATA PHARMACEUTICALS INC (RETA). They have executed 48 insider transactions totaling $26.6M over their tenure at the company.
Colin John Meyer holds the position of Executive at REATA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Colin John Meyer has shown a selling trading pattern, with $223.8K in total purchases and $26.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Colin John Meyer was on Nov 9, 2020, when they sold $4.4M worth of RETA shares. This transaction involved 25,000 shares at $175.00 per share.
Colin John Meyer currently owns 81,633 shares of REATA PHARMACEUTICALS INC (RETA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Colin John Meyer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Colin John Meyer has 48 Form 4 filings on record as an insider at REATA PHARMACEUTICALS INC.
Set alerts for Colin John Meyer and 40,000+ other insiders.